2022, Number 8
<< Back
Med Crit 2022; 36 (8)
Plasminogenesis disfunction in critical ilness patient with polimicrobial infection associated glycoproteins deficiency
Giraldo JM, Giraldo JM, Duque C
Language: Spanish
References: 22
Page: 528-533
PDF size: 337.70 Kb.
ABSTRACT
We present the clinical case of a 59-year-old patient with sepsis due to polymicrobial pneumonia with viral isolates conditioning bacterial infection and thrombosis. His chest scannography reported basals collapses with atelectasis and reticular interstitial infiltrates; Evolved with cognitive impairment related to multi-infarction vascular brain disease documented by single-photon emission brain tomography by nuclear medicine due to normal scannographies studies; Given the neurological evolution, extension studies were carried with transthoracic duplex Doppler echocardiogram which was normal, as well as a contrasted study of four neck vessels, electrical rhythm holter and complete metabolic profile also normal. We conducted a review in the literature with a view to providing understanding and evidence of the direct relationship between septic syndromes and viral infections with different states of hypercoagulability, inflammation and apoptosis.
REFERENCES
Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38-44, http://dx.doi.org/10.1016/j.thromres.
Hartmut W. Regulation and inflammation by protein C system. Crit Care Med. 2010;38(2):S18-25.
Broze GJ Jr. Thrombin-dependent inhibition of fibrinolysis. Curr Opin Hematol. 1996;3:390-394.
Leung LL, Myles T, Nishimura T, et al. Regulation of tissue inflammation by thrombin activatable fibrinolysis inhibitor. Mol Immunol. 2008;45:4080-4083.
Van de Wouwer M, Conway EM: Novel function of thrombomoduline in inflammation. Crit Care Med. 2004;32:s254-s261.
Abeyama K, Stern DM, Ito Y, et al. The N-terminal domain of Thrombomoduline sequesters of high mobility Box 1 Protein., a novel antiinflammatory mechanism. J Clin Invest. 2005;115:1267-1274.
Hagiwuara S, Iwasaka H, Matsumoto S, et al: In vivo in vitro effects of the anticoagulants, thrombomoduline, on the inflammatory response in roden models. Shock. 2010;33(3):282-288.
Laridan E, Denorme F, Desender L, et al. Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol. 2017;82(2):223-232. doi: 10.1002/ana.24993.
Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost. 2019;45(1):86-93. doi: 10.1055/s-0038-1677040.
Lee KH, Cavanaugh L, Leung H, et al. Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis. Int J Lab Hematol. 2018;40(4):392-399. doi: 10.1111/ijlh.12800.
Elaskalani O, Abdol Razak NB, Metharom P. Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones. Cell Commun Signal. 2018;16(1):24. doi: 10.1186/s12964-018-0235-0.
Shin HS, Xu F, Bagchi A, et al. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J Immunol. 2011;186:1119-1130, http://dx.doi.org/10.4049/jimmunol.1001647.
Palmer OM, Carter M, Chang CH, et al. Effects of transport temperature on the stability of inflammatory, hemostasis endothelial function and oxidative stress plasma biomarker concentrations. Shock. 2016;22:715-719.
Abramson JS, Mills EL. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis. 1988;10:326-341. doi: 10.1093/clinids/10.2.326.
Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962-970. doi: 10.1086/591708.
Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309:275-282. doi: 10.1001/jama.2012.194139.
Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun. 2015;83:3764-3770. doi: 10.1128/IAI.00298-15.
Angus DC, Yang L, Kong L, et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med. 2007;35(4):1061-1067.
Shirey K, Lai W, Scott A, et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature. 2013;497:498-502. doi: 10.1038/nature12118.
Iba T, Arakawa M, Di Nisio M, et al. Newly proposed sepsis-induced coagulopathy precedes international society on thrombosis and haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2020;35(7):643-649. doi: 10.1177/0885066618773679.
Samuels JM, Moore HB, Moore EE. Coagulopathy in severe sepsis: interconnectivity of coagulation and the immune system. Surg Infect (Larchmt). 2018;19(2):208-215. doi: 10.1089/sur.2017.260.
Alberti S, DI Pasquale M, Zanaboni AM, et al. Stratifyng risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Cli Infec Diseases. 2012;54:470-478.